Cargando...

Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context

Abstract Background Biomarkers such as amyloid imaging are increasingly used for diagnosis in the early stages of Alzheimer’s disease. Very few studies have examined this from the perspective of the patient. To date, there is only limited evidence about how patients experience and value disclosure i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gwendolien Vanderschaeghe, Jolien Schaeverbeke, Rose Bruffaerts, Rik Vandenberghe, Kris Dierickx
Formato: Artigo
Lenguaje:Inglês
Publicado: BMC 2017-12-01
Colección:Alzheimer’s Research & Therapy
Materias:
Acceso en línea:http://link.springer.com/article/10.1186/s13195-017-0321-3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!